eShowcase: EDC 2.0
New Version of EDC Solution Builds on Web Capabilities for Integration and Study Deployment
New Version of EDC Solution Builds on Web Capabilities for Integration and Study Deployment
etrials Worldwide (Morrisville, NC) has released EDC 2.0, the latest version of its software for pharmaceutical companies used to collect, manage, and analyze clinical trial information.
EDC 2.0 is Web-based and can integrate with etrials eDiary and IVR solutions to provide a more comprehensive e-clinical solution.
Also, because it is Web-based, it can be accessed by study sites and provides user-directed functions and design. The product also includes new reporting and configuration capabilities. Other functions include Electronic Case Report Forms (eCRF), workflow manager, a Message/Alert manager that uses a message center to connect and communicate with sites and investigators, a Reporting/Analytics function, and a Design Manager to improve application interfaces for increased user function.
Data is housed in a single data repository and includes the ability to integrate study-related data using Data Xchange.
etrials Worldwide, (919) 653-3400, www.etrials.com
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
